格林大华期货研究院 证监许可【2011】1288 号 2025 年 7 月 1 日星期二 早盘提示 Morning session notice 更多精彩内容请关注格林大华期货官方微信 研究员： 于军礼 从业资格： F0247894 交易咨询资格：Z0000112 联系方式：yujunli@greendh.com | 板块 | 品种 | 多（空） | | | --- | --- | --- | --- | | | | | 【重要资讯】 | | | | | 1、达利欧称，在接下来的一年里，美国必须出售大约 12 万亿美元国债。需要 1 万 | | | | | 亿美元支付利息，有 9 万亿美元的债务要偿还，必须再出售 2 万亿美元债务，因为 | | | | | 有赤字 2 万亿美元。债务增长累似动脉斑块淤积，美国财政心脏病会随时发作。 | | | | | 2、尽管共和党参议员勉强凑齐票数开启辩论，但法案的最终通过仍悬而未决，其 | | | | | 潜在的巨额债务规模引发党内外担忧，马斯克称之为"荒唐且具有破坏性"，一些 | | | | | 不寻求连任的参议员对法案投下反对票。 | | | | | 3、高盛认为，美 ...

贸易协议希望推动标普500指数再创新高，Q2创一年半最大季度涨幅；上半年美债创五年同期最 佳表现、美元创1973年来最大同期跌幅。 报道称欧盟愿意接受美国对多类商品10%关税税率，但希望把关键行业排除在外。 加拿大让步，取消数字服务税，美加将恢复贸易谈判，以期在7月21日前达成协议。 美国财长贝森特称无意增加长期美债发行比重；稳定币立法或7月中出台。 特朗普扩大攻击对象，批评包括鲍威尔在内的美联储理事会；白宫称特朗普周一致信美联储提及 全球利率。 中国6月官方制造业PMI连升两月至49.7，新订单指数回升至扩张区间，非制造业延续扩张。 重大转变：苹果被爆考虑外部AI技术赋能Siri、用第三方Anthropic或OpenAI的AI模型；郭明錤： 苹果在憋"大招"，七款头显、AI眼镜在研，2027年会是大爆发期。 甲骨文拿下云大单，一年创收300亿，股价一度涨超8%，创历史新高。 ...

中东专场上，亚投行阿布扎比业务中心首席代表、商务部国际经贸关系司原副司长孙元江以亚投行在阿 联酋阿布扎比设立办公室的经历为切入点，分析了中东地区成为全球投资热土的多重因素。 凤凰网财经讯 6月28-29日，"2025中国企业出海高峰论坛"在深圳举行，本次论坛由凤凰网主办，雪花超 高端系列品牌-醴首席赞助合作，中国企业出海全球化理事会联合主办，以"为开放的世界"为主题，旨 在全球产业链深度重构之际，为中国企业搭建思想碰撞、资源对接、规则对话的高端平台，系统性破解 出海难题，共探生态共赢转型路径。 亚投行阿布扎比业务中心首席代表、商务部国际经贸关系司原副司长孙元江 孙元江指出，沙特、阿联酋等国正积极推进经济多元化战略，他们很注重再生能源的领域，还有一些高 科技的，AI技术、数据的基础设施、生物，"我觉得这些领域包括物流、房地产都是企业可以关注的领 域和方向。" 点击 " 阅读原文 " 了解更多详情 ！ 孙元江透露，亚投行选择在阿布扎比设立首个海外办公室，最初是出于疫情期间国际旅行的实际需求。 阿联酋早早放开旅行限制，加之其地处亚非欧交汇处的8小时航空圈核心位置，可高效覆盖非洲、中 东、中亚和南亚等关键市场，最终促 ...

Core Viewpoint - The event "Rational Investment Accompanies Me, Entering Listed Companies" aimed to enhance communication between investors and listed companies, promoting rational, value, and long-term investment principles [1] Group 1: Company Overview - Aier Eye Hospital is the largest ophthalmology medical group globally, with plans to operate 900 brand hospitals, eye centers, and clinics by the end of 2024, achieving an annual outpatient volume of 16.94 million and nearly 1.3 million surgeries [2] - The company employs a tiered chain model to efficiently allocate medical resources, improving grassroots medical service levels while meeting diverse patient needs [2] - Aier Eye Hospital has been pursuing international expansion since 2014, acquiring excellent overseas targets to better understand global advancements and integrate advanced ophthalmic technologies into its domestic operations [2] Group 2: Technological Innovation - The company is actively exploring the application of AI technology in ophthalmology, collaborating with research institutions to analyze eye images using AI algorithms, enhancing diagnostic efficiency and accuracy [3] - Aier Eye Hospital is developing AI-assisted wearable devices for myopia prevention in children, which monitor eye usage and provide feedback to parents [2][3] Group 3: Investor Engagement - During the event, investors engaged in discussions about AI applications, talent strategies, and overseas market expansion, reflecting their interest in the company's innovative approaches [2] - The event included a tour of Aier Eye Hospital's facilities, showcasing its achievements in eye health education, medical services, research, and talent development [3]

1.《 Shippeo领导层任命与市场定位 》摘要 ■ 全球领先的实时多模式运输可视化（RTTV）公司Shippeo宣布任命Brandon Oliveri-O'Connor为 首席营收官（CRO），Ben Douglass为首席营销官（CMO）。 ■ 他们曾在Procore担任关键职务，并帮助该平台从5,000万美元的年经常性收入（ARR）增长到10亿 美元。 ■ Oliveri-O'Connor和Douglass带来了在复杂行业中扩展SaaS公司的丰富经验，特别是在欧洲、英 国和中东市场。 ■ 预计他们的加入将推动Shippeo的增长，尤其是他们在理解行业挑战和利用技术解决这些问题方面 的专长。 ■ 在新领导团队的推动下，Shippeo计划进一步提升其市场领先的运输可视化平台，改善客户体验， 并继续构建具有韧性和可持续性的供应链。 ■ Shippeo的网络与超过22.8万家承运商及1,100个运输管理系统（TMS）、遥测和电子驾驶日志 （ELD）系统集成，平台每年跟踪超过9,000万次货运，覆盖150个国家。 2、《115.6亿元并购过会！TCL科技收购华星半导体21%股权》摘要 ■ TCL科技拟通过现金及 ...

Core Insights - The core viewpoint of the articles emphasizes the significant advancements in China's electricity market since the initiation of the "new round of electricity system reform" in 2015, highlighting the transition towards a market-oriented trading system and the increasing participation of various stakeholders in electricity trading [1][4][7]. Group 1: Market Development - By 2024, the national market-oriented trading electricity volume reached 6.2 trillion kilowatt-hours, accounting for 63% of the total electricity consumption, a substantial increase from 17% in 2016 [1]. - The electricity market is evolving with the full rollout of the spot market and the imminent entry of renewable energy generation, leading to the emergence of new trading models worth hundreds of billions to trillions [3][4]. - The establishment of a comprehensive electricity market is expected to significantly influence all electricity producers and consumers, optimizing resource allocation and promoting green economic benefits [4][10]. Group 2: Challenges for Small and Medium Enterprises - The complexity of the electricity trading market poses significant challenges for small and medium enterprises, as the need for real-time balancing and the high technical barriers to entry become apparent [5]. - Despite the continued role of the grid in providing basic services, the focus has shifted towards ensuring system stability rather than assisting users in market positioning [5]. - The value of technology-driven electricity sales companies is increasingly recognized, with companies like Langxin rapidly expanding their trading volumes and maintaining a 100% performance rate over three years [5][6]. Group 3: Renewable Energy Marketization - The recent policy changes, particularly the issuance of document 136 by the National Development and Reform Commission, mandate that renewable energy projects will primarily enter the electricity market, marking a pivotal shift in industry investment logic [7]. - By 2024, the market-oriented trading proportion of renewable energy generation is expected to approach 50%, reflecting the rapid growth in installed capacity and generation share of renewable sources [7][8]. - The market environment introduces greater revenue uncertainty for renewable energy projects, necessitating advanced strategies for price optimization and risk management [7]. Group 4: AI and Technology in Electricity Trading - The rapid development of AI technology is providing new methodologies for electricity trading decisions, enhancing predictive capabilities across various dimensions [9]. - Langxin Technology is leveraging AI to optimize trading decisions and customer management, demonstrating significant success in real-world applications [9][10]. - The future of the electricity market will see the emergence of new market entities such as virtual power plants and microgrids, where AI will play a crucial role in enhancing operational efficiency and market responsiveness [10].

Core Insights - Enya, a sanitary napkin brand, has secured several million dollars in seed funding from 500Global, aimed at brand building and expanding into the Chinese market [1] - The company anticipates a doubling of revenue this year, with projections to exceed $10 million next year following its entry into China [2] Company Overview - Enya, founded in 2020 in Singapore, focuses on digital menstrual care and has expanded into markets including Singapore, Malaysia, Hong Kong, UAE, and Saudi Arabia, with a recent entry into mainland China [1] - The founder, Chris Teo, is an experienced entrepreneur with a background in FinTech and Femtech, aiming to leverage his expertise in cost management and efficiency in the fast-moving consumer goods (FMCG) sector [1] Product Offering - Enya's product range includes sanitary napkins, heating pads, menstrual cups, and menstrual pants, with sanitary napkins being the primary product in China, made from 100% organic cotton [4] - The products have received FDA certification, which requires passing 16 heavy metal tests and 3 categories of pathogenic bacteria tests, exceeding national standards by approximately three times [5] Market Strategy - Enya has established strong channel capabilities, primarily focusing on offline sales due to limited online payment options and logistics in Southeast Asia, partnering with convenience store brands like 7-11 and Watsons, and is set to collaborate with Sam's Club [8] - The company aims to increase its sales share in China to 70%-80% of its total revenue, capitalizing on the growing sanitary napkin market, which is projected to maintain a compound annual growth rate of 5%-8% and exceed 105 billion yuan by 2025 [9] Competitive Landscape - The sanitary napkin market in China is currently facing a trust crisis due to production issues highlighted in media reports, leading to a potential market reshuffle [9] - Enya plans to introduce products tailored to Asian body types and intends to integrate AI technology for personalized consumer experiences through a WeChat mini-program [9] Distribution Channels - Enya's strategy includes a "full-scenario penetration" approach, developing a three-tier distribution network comprising instant retail (Meituan/JD Daojia), high-end convenience stores (FamilyMart/Rosen), and supermarket systems (Yonghui/Darunfa) [10] - The company aims to penetrate over 8,000 convenience store terminals to reshape consumer brand perception and enhance product availability, while also expanding online sales through platforms like Xiaohongshu, Tmall, and JD [10]

Core Viewpoint - Dongyang Sunshine Pharmaceutical is pursuing a unique "zero fundraising IPO" strategy by merging with its subsidiary Dongyang Sunshine Changjiang Pharmaceutical, aiming to enhance its competitive position in the pharmaceutical industry [2][3]. Group 1: Listing Strategy - The company plans to go public in Hong Kong through a merger with its subsidiary, which will involve issuing H-shares to shareholders without raising new funds [3]. - This unconventional approach is intended to consolidate its pharmaceutical assets and create a comprehensive pharmaceutical company that integrates R&D, production, and commercialization [3]. Group 2: Market Position - Dongyang Sunshine Pharmaceutical holds a dominant position in the domestic market for its core product, Oseltamivir Phosphate, ranking first in 2024 [2]. - The sales contribution of Oseltamivir Phosphate to total revenue has fluctuated but remains a crucial support for the company's performance from 2022 to 2024 [2]. Group 3: R&D and Innovation - The company has established a robust R&D platform with over 1,100 professionals, focusing on various therapeutic areas including infections, chronic diseases, and oncology [8]. - Dongyang Sunshine has a diverse portfolio of over 150 approved drugs and more than 100 drugs in development, with 49 first-class innovative drugs [8][9]. - The company has invested significantly in R&D, with expenditures of 792 million yuan, 827 million yuan, and 888 million yuan from 2022 to 2024, representing 20.8%, 13.0%, and 22.1% of total revenue respectively [9]. Group 4: Business Development (BD) Collaborations - The company is actively engaging in BD collaborations to expand its commercialization pathways, including a notable agreement with Apollo Therapeutics valued at $938 million for a dual-specific fusion protein [6][7]. - Dongyang Sunshine is one of the few Chinese pharmaceutical companies developing insulin products for the U.S. market, showcasing its global resource integration capabilities [7]. Group 5: AI Technology in R&D - The company is leveraging AI technology across various stages of drug development, having established multiple advanced AI-driven models to enhance innovation and efficiency [9]. - A recent AI-driven first-class new drug, HEC169584, has been approved for clinical trials targeting non-alcoholic fatty liver disease (NASH) [9].

Core Viewpoint - The anime industry is at a technological crossroads due to the rapid integration of AI, facing a significant supply-demand imbalance while exploring AI's potential in production processes [1][3]. Group 1: Current State of the Anime Industry - The anime industry is experiencing a historical supply-demand split, with top studios having schedules booked two years in advance, leading to a production bottleneck [3][6]. - The global anime market is growing at over 10% annually, driven by a younger demographic that has grown up with anime, including Gen Z and Gen Alpha [6][8]. - Production in the anime industry remains highly labor-intensive, with 30%-40% still relying on traditional hand-drawn methods, indicating a low level of industrialization and digitalization [8][9]. Group 2: AI Integration Paradigms - Three main types of companies are emerging in the AI-anime space: traditional studios looking to enhance efficiency with AI, disruptive startups rethinking production processes around AI, and hybrid models using AI as an assistant [9][17][24]. - Traditional studios are exploring AI to optimize specific production steps, such as in-between frame generation, but face challenges with stability and quality [10][12]. - Disruptive companies like KAKA Creation are attempting to create content primarily through AI, but often struggle with maintaining the artistic quality and exaggerated aesthetics typical of traditional anime [17][19]. Group 3: Challenges and Future Prospects - The current limitations of AI in generating stable and coherent video content pose significant challenges, with most models generating videos of only 10-20 seconds [32][34]. - The anime industry faces ethical dilemmas regarding AI-generated content, particularly concerning voice acting and the potential displacement of human creators [36][37]. - There is a growing interest in how AI can enhance creative possibilities, such as complex costume designs that were previously too labor-intensive to produce [28][29].

上海电信打造的400GE IP城域智算POD将成为联接企业园区和运营商智算中心的数字底座，并推出云边 协同训推方案，为企业提供高品质算网一体服务。为了匹配训推算力快速增长的需求，企业可以优化模 型部署，将涉及私有数据的模型部分部署在本地算力服务器，其余部署在运营商智算中心内，本地算力 和云端算力通过智算广域网来传输不可还原的中间数据层，保护企业敏感数据不泄露。分布式训推模式 一方面能够满足企业数据传输安全的诉求，另一方面使得企业可以灵活租赁运营商的算力资源来实现算 力按需扩缩容。经现网测试验证，基于华为AI WAN智算广域网解决方案提供的RDMA无损传输技术可 以实现跨240公里拉远推理效率不下降。 张坚平表示，为了进一步推动我国算力基础设施高质量发展，作为城市信息化建设主力军，上海电信与 华为及企业多方携手，一起迎接智算网络关键技术挑战，在垂直行业场景进行方案验证，最终实现算网 一体服务商业落地。 来源：中国网 【中国，上海，2025年06月18日】在由中国信息通信研究院主办的智能IP广域网(AI WAN)产业论坛 上，中国电信股份有限公司上海分公司（以下简称"上海电信"）高级副总工程师张坚平分享了"智云上 ...